Vifor (International) Ltd. v. Eris Lifesciences Limited

Patent battles are rarely won in a single courtroom showdown. More often, they unfold in a slow, strategic war of interim applications, status quo orders, and conditional reliefs, where every ruling shapes the commercial battlefield long before the final verdict. The dispute between Vifor (International) Ltd. and Eris Lifesciences Limited is a textbook example of how complex, layered, and uncertain this interim phase can be, especially when the underlying technology is as scientifically nuanced as a water-soluble iron carbohydrate complex.

Vifor (International) Ltd. and another entity, the plaintiffs in the matter, are the holders of Indian Patent IN 221536, which covers a Water Soluble Iron Carbohydrate Complex, a pharmaceutical formulation with significant therapeutic applications. Vifor filed multiple suits against Eris Lifesciences Limited and others, alleging infringement of this patent. Alongside the main suits, Vifor moved several interim applications seeking urgent relief, including injunctions to restrain Eris from manufacturing or selling the allegedly infringing product. The stage was already set by a prior judgment from a Coordinate Bench, which had dismissed Vifor's interim injunction applications, leaving the patent holder searching for alternative interim remedies.

Vifor's central argument was straightforward: as the holder of a valid patent, it was entitled to protective orders that would preserve its market position and prevent irreparable harm while the infringement question was being adjudicated. The plaintiffs pushed for measures that would effectively halt Eris's commercial activity or, at the very least, force the defendants to deposit their entire sales proceeds into court as a form of financial security. Eris and the other respondents, meanwhile, relied on the Coordinate Bench's earlier dismissal of the injunction applications, arguing that the court had already found no basis for restraining their operations. The legal friction was clear: Vifor wanted the court to step in with strong interim measures, while the defendants pointed to the prior ruling as a reason for the court to stay its hand.

The court took a measured, middle-ground approach. Recognizing that the Coordinate Bench had already dismissed the interim injunction applications, the court vacated the existing status quo orders. However, it did not leave the defendants entirely free to operate without constraints. The court imposed specific conditions aimed at preventing Eris from following the patented process, thereby drawing a careful line between commercial activity and process-level infringement. At the same time, the court declined Vifor's request for an order directing Eris to deposit its entire sales amount. The reasoning was rooted in judicial caution: granting such a sweeping financial remedy would require a prima facie finding of infringement, and that determination was still pending before the Division Bench. In other words, the court was unwilling to impose a heavy-handed financial condition without the foundational infringement ruling that only the Division Bench could provide.

For founders, startup leaders, and IP professionals, this case offers a sharp reminder: interim relief in patent disputes is not a guaranteed shield, and courts will rarely impose drastic financial conditions, like full sales deposits, without a prima facie finding of infringement. If your business relies on a patented process or formulation, do not assume that filing for an injunction will automatically halt a competitor's operations. Build your interim strategy around the strength of your prima facie case, because courts are increasingly willing to vacate status quo orders once a Coordinate Bench has rejected injunction pleas. Equally, if you are on the defending side, a prior dismissal of injunction applications can be a powerful lever, but it is not a permanent shield, courts can and do impose targeted conditions to prevent specific infringing acts even when full injunctions are denied. The lesson is clear: in patent litigation, the interim phase is its own battleground